Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORETOX vs BOTOX in Post-Stroke Upper Limb Spasticity
NCT03289702Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Nov 2017
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in Spasticity (2 arms), sponsored by Medytox Inc. Primary endpoint: Modified Ashworth Scale of wrist flexor at 4 weeks. Started Nov 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT03289702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289702.